Drug General Information
Drug ID
D02TTL
Former ID
DCL001179
Drug Name
Debio 0932
Indication Cancer [ICD9: 140-229; ICD10:C00-C96] Phase 1 [550597]
Company
Debiopharm
Target and Pathway
Target(s) Heat shock protein HSP90 Target Info Inhibitor [550597]
References
Ref 550597Clinical pipeline report, company report or official report of Debiopharm (2011).
Ref 550597Clinical pipeline report, company report or official report of Debiopharm (2011).